Deciphera Pharmaceuticals competitors and similar companiesClear all
Deciphera Pharmaceuticals's competitors and similar companies include Exelixis, Bristol-Myers Squibb, Blueprint Medicines, Arog Pharmaceuticals and Allakos.
 Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. |  Exelixis Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. |  Blueprint Medicines Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders. |  Arog Pharmaceuticals Arog Pharmaceuticals is a biopharmaceutical company dedicated to improving the lives of cancer patients by developing crenolanib in indications with high unmet need. |  Allakos Allakos, a biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases. | ||
Founding Date | Founding Date 2003 | Founding Date 1994 | Founding Date 1887 | Founding Date 2011 | Founding Date 2010 | Founding Date 2012 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | ||||||
Locations | Locations Waltham, US HQ Lawrence, US | Locations Alameda, US HQ | Locations New York, US HQ Wien, AT Braine L'alleud, BE Bruxelles, BE São Paulo, BR Montréal, CA Shanghai, CN see more | Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH | Locations Plano, US HQ | Locations Redwood City, US HQ San Carlos, US |
Employees | Employees 35037% increase | Employees 61727% increase | Employees 32,2006% increase | Employees 49515% increase | Employees 910% decrease | Employees 967% increase |
Valuation ($) | Valuation ($) 1.1 b | Valuation ($) 5.7 b | Valuation ($) 141.6 b | Valuation ($) 2.7 b | Valuation ($) N/A | Valuation ($) 468.6 m |
Twitter followers | Twitter followers 748 | Twitter followers 5.8 k | Twitter followers 157.5 k | Twitter followers 2.7 k | Twitter followers N/A | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 4 | Number of tweets (last 30 days) 7 | Number of tweets (last 30 days) 26 | Number of tweets (last 30 days) 13 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 4.3 | Average likes per tweet (last 30 days) 1.4 | Average likes per tweet (last 30 days) 9.4 | Average likes per tweet (last 30 days) 4.9 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 71.43% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 92.31% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A |
Employee Rating | Employee Rating 3.7 | Employee Rating 2.7 | Employee Rating 3.9 | Employee Rating 4.2 | Employee Rating 1.8 | Employee Rating 4.4 |
Financial | ||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.6b (FY, 2022) | Revenue (est.) $46.2b (FY, 2022) | Revenue (est.) $204m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $57.9m (FY, 2022) | Cost of goods $10.1b (FY, 2022) | Cost of goods $17.8m (FY, 2022) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $1.6b (FY, 2022) | Gross profit $36b (FY, 2022) | Gross profit $186.2m (FY, 2022) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($25.9m) (FY, 2016) | Net income $182.3m (FY, 2022) | Net income $6.3b (FY, 2022) | Net income ($557.5m) (FY, 2022) | Net income ($11.6m) (FY, 2017) | Net income ($320m) (FY, 2022) |
Funding | ||||||
Total funding raised | Total funding raised $ 714m | Total funding raised N/A | Total funding raised $ 15.5m | Total funding raised $ 1.7b | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Exelixis
HQ
Alameda, US
Employees
617↑ 27% increase
Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.
View company
Bristol-Myers Squibb
HQ
New York, US
Employees
32,200↑ 6% increase
Bristol-Myers Squibb is a company that provides biopharmaceutical products.
View companyBlueprint Medicines
HQ
Cambridge, US
Employees
495↑ 15% increase
Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.
View companyArog Pharmaceuticals
HQ
Plano, US
Employees
9↓ 10% decrease
Arog Pharmaceuticals is a biopharmaceutical company dedicated to improving the lives of cancer patients by developing crenolanib in indications with high unmet need.
View company